Optimizing Fall-risk Prediction in Older Adults With Cancer
Completed
- Conditions
- Cancer
- Registration Number
- NCT02912273
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 227
Inclusion Criteria
- Age ≥65
- Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents or hormonal agents (e.g. anti-estrogen or anti-androgen) OR will begin systemic therapy within the next 4 weeks.
- Estimated life expectancy >1 year
- Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
- Able to understand and willing to sign an IRB-approved written informed consent document
Exclusion Criteria
- Unable to read and understand English
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of falls Up to 6 months -The Prevention of Falls Network Europe (PROFANE) Consensus Group guidelines will be used
- Secondary Outcome Measures
Name Time Method Time to fall event Up to 6 months Number of falls that were considered injurious falls Up to 6 months Fear of falling as Measured by the Falls Efficacy Scale-International Up to 6 months measures the level of concern about falling during social and physical activities inside and outside the home whether or not the person actually does the activity. The level of concern is measured on a four point Likert scale (1=not at all concerned to 4=very concerned)
Overall survival Up to 6 months
Trial Locations
- Locations (1)
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States
Washington University School of Medicine🇺🇸Saint Louis, Missouri, United States